Hypolipidemic, antiobesity and cardioprotective effects of sardinelle meat flour and its hydrolysates in high-fat and fructose diet fed Wistar rats

Life Sciences

Volumn 176, Issue , 2017, Pages 54-66

  Jemil, Ines ^a   Abdelhedi, Ola ^a   Nasri, Rim ^a   Mora, Leticia ^d   Marrekchi, Rim ^c   Jamoussi, Kamel ^c   ElFeki, Abdelfattah ^b   Hajji, Mohamed ^a   Toldrá, Fidel ^d   Nasri, Moncef ^a  

^a UNIVERSITY OF SFAX   (Tunisia)

^b UNIVERSITY OF SFAX   (Tunisia)

^c HEDI CHAKER HOSPITAL   (Tunisia)

^d INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

Author keywords

Antiobesity; Cardioprotective; Fermented sardinelle protein hydrolysates; High caloric diet; Hypolipidemic

Indexed keywords

FRUCTOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN HYDROLYSATE; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; ANTILIPEMIC AGENT; FAT INTAKE; FISH PROTEIN; LIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACILLUS AMYLOLIQUEFACIENS; BACILLUS SUBTILIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; EPIDIDYMIS FAT; FERMENTATION; FISH MEAT; FOOD INTAKE; HEART INFARCTION; HEART PROTECTION; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; RAT; SARDINELLA AURITA; TRIACYLGLYCEROL BLOOD LEVEL; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; ADVERSE EFFECTS; ANIMAL; BLOOD; CHEMICALLY INDUCED; CHEMISTRY; FAT INTAKE; FISH MEAL; OBESITY; PATHOPHYSIOLOGY; PHARMACOLOGY; WISTAR RAT;

ANIMALS; DIETARY FATS; FISH FLOUR; FISH PROTEINS; FRUCTOSE; HYPOLIPIDEMIC AGENTS; LIPIDS; MALE; OBESITY; PROTEIN HYDROLYSATES; RATS; RATS, WISTAR;

EID: 85016837564     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2016.07.012     Document Type: Article

References (59)

1. [1] Jain, K.S., Kathiravan, M.K., Somani, R.S., Shishoo, C.J., The biology and chemistry of hyperlipidemia. Bioorg. Med. Chem. 15 (2007), 4674–4699.
2. [2] Korhonen, T., Savolainen, M.J., Koistinen, M.J., Ikaheimo, M., Linnaluoto, M.K., Kervinen, K., et al. Association of lipoprotein cholesterol and triglycerides with the severity of coronary artery disease in men and women. Atherosclerosis 127 (1996), 213–220.
3. [3] Ben Khaled, H., Ghlissi, Z., Chtourou, Y., Hakim, A., Ktari, N., Makni Ayadi, F., et al. Effect of protein hydrolysates from sardinelle (Sardinella aurita) on the oxidative status and blood lipid profile of cholesterol-fed rats. Food Res. Int. 45 (2012), 60–68.
4. [4] Ktari, N., Mnafgui, K., Nasri, R., Hamden, K., Bkhairia, I., Ben Hadj, A., et al. Hypoglycemic and hypolipidemic effects of protein hydrolysates from zebra blenny (Salaria basilisca) in alloxan-induced diabetic rats. Food Funct. 4 (2013), 1691–1699.
5. [5] Lassoued, I., Trigui, M., Ghlissi, Z., Nasri, R., Jamoussi, K., Kessis, M., et al. Evaluation of hypocholesterolemic effect and antioxidant activity of Boops boops proteins in cholesterol-fed rats. Food Funct. 5 (2014), 1224–1231.
6. [6] Sugano, M., Goto, S., Yamada, Y., Yoshida, K., Hashimoto, Y., Matsuo, T., et al. Cholesterol-lowering activity of various undigested fractions of soybean protein in rats. J. Nutr. 120 (1990), 977–985.
7. [7] Zhang, X., Beynen, A.C., Lowering effect of dietary milk whey protein v. casein on plasma and liver cholesterol concentrations in rats. Br. J. Nutr. 70 (1993), 139–146.
8. [8] Zhong, F., Liu, J., Ma, J., Shoemaker, C.F., Preparation of hypocholesterol peptides from soy protein and their hypocholesterolemic effect in mice. Food Res. Int. 40 (2007), 661–667.
9. [9] Wergedahl, H., Liaset, B., Gudbrandsen, O.A., Lied, E., Espe, M., Muna, Z., et al. Fish protein hydrolysate reduces plasma total cholesterol, increases the proportion of HDL cholesterol, and lowers acyl-CoA:cholesterol acyltransferase activity in liver of Zucker rats. J. Nutr. 134 (2004), 1320–1327.
10. [10] Qian, Z.J., Jung, W.K., Lee, S.H., Byun, H.G., Kim, S.K., Antihypertensive effect of an angiotensin I-converting enzyme inhibitory peptide from bullfrog (Rana catesbeiana Shaw) muscle protein in spontaneously hypertensive rats. Process Biochem. 42 (2007), 1443–1448.
11. [11] Duarte, J., Vinderola, G., Ritz, B., Perdigon, G., Matar, C., Immunomodulating capacity of commercial fish protein hydrolysate for diet supplementation. Immunobiology 211 (2006), 341–350.
12. [12] Fitzgerald, A.J., Rai, P.S., Marchbank, T., Taylor, G.W., Ghosh, S., Ritz, B.W., et al. Reparative properties of a commercial fish protein hydrolysate preparation. Gut 54 (2005), 775–781.
13. [13] Urquiaga, I., Guasch, V., Marshall, G., San Martin, A., Castillo, O., Rozowski, J., et al. Effect of Mediterranean and occidental diets, and red wine, on plasma fatty acids in humans. An intervention study. Biol. Res. 37 (2004), 253–261.
14. [14] Getz, G.S., Reardon, C.A., Nutrition and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol. 27 (2007), 2499–2506.
15. [15] Messerli, M.L., Parmley, T., Woodruff, J.D., Lilienfeld, A.M., Bevilacqua, L., Rosenshein, N.B., Inter- and intra-pathologist variability in the diagnosis of gestational trophoblastic neoplasia. Obstet. Gynecol. 69 (1987), 622–626.
16. [16] George, V., Tremblay, A., Després, J.P., Leblanc, C., Bouchard, C., Effect of dietary fat content on total and regional adiposity in men and women. Int. J. Obes. 14 (1990), 1085–1094.
17. [17] Tucker, L.A., Kano, M.J., Dietary fat and body fat: a multivariate study of 205 adult females. Am. J. Clin. Nutr. 56 (1992), 616–622.
18. [18] Zou, Y., Li, J., Lu, C., Wang, J., Ge, J., Huang, Y., et al. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis. Life Sci. 79 (2006), 1100–1107.
19. [19] Kasim-Karakas, S.E., Vriend, H., Almario, R., Chow, L.C., Goodman, M.N., Effects of dietary carbohydrates on glucose and lipid metabolism in golden Syrian hamsters. J. Lab. Clin. Med. 128 (1996), 208–213.
20. [20] Cuvier, G., Valenciennes, A., Histoire naturelle des poissons. Tome vingtième. Livre vingt et unième. De la famille des Clupéoïdes. Histoire Naturelle des Poissons. i-xviii, 1, 1847, 1–472.
21. [21] FAO-Sofia, The State of World Fisheries and Aquaculture (SOFIA) 2012. 2012, FAO Fisheries Department, Rome.
22. [22] Jemil, I., Jridi, M., Nasri, R., Ktari, N., Ben Slama-Ben Salem, R., Hajji, M., et al. Functional, antioxidant and antibacterial properties of protein hydrolysates prepared from fish meat fermented by Bacillus subtilis A26. Process Biochem. 49 (2014), 963–972.
23. [23] Agrebi, R., Haddar, A., Hajji, M., Frikha, F., Manni, L., Jellouli, K., et al. Fibrinolytic enzymes from a newly isolated marine bacterium Bacillus subtilis A26: characterization and statistical media optimization. Can. J. Microbiol. 55 (2009), 1049–1061.
24. [24] Agrebi, R., Hmidet, N., Hajji, M., Ktari, N., Haddar, A., Fakhfakh-Zouari, N., et al. Fibrinolytic serine-protease from Bacillus amyloliquefaciens An6 grown on Mirabilis jalapa tuber powders: production, partial purification and biochemical characterization. Appl. Biochem. Biotechnol. 162 (2010), 75–88.
25. [25] Friedewald, T., Levy, T., Fredrickson, S., Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 226 (1972), 499–502.
26. [26] Crook, M., Plasma lipids and lipoproteins. Clin. Biochem. Metab. Med. 7 (2006), 198–213.
27. [27] Tan, H., Johns, D., Glazer, B., Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes. Clin. Chem. 50 (2004), 1184–1188.
28. [28] Seki, M., Ishiguro, T., Gyouda, Y., Evaluation of the efficacy of coronary risk index, a new scoring system for predicting morbidity and severity of coronary stenosis in patients undergoing coronary angiography. J. Jpn. Soc. Clinic. Anesth. 18 (1998), 271–276.
29. [29] Nakai, M., Fukui, Y., Asami, S., Toyoda-Ono, Y., Iwashita, T., Shibata, H., et al. Inhibitory effects of oolong tea polyphenols on pancreatic lipase in vitro. J. Agric. Food Chem. 53 (2005), 4593–4598.
30. [30] Lemieux, L., Piot, J.M., Guillochon, D., Amiot, J., Study of the efficiency of a mobile phase used in size-exclusion HPLC for the separation of peptides from a casein hydrolysate according to their hydrodynamic volume. Chromatographia 31 (1991), 499–504.
31. [31] Mullally, M.M., Meisel, H., FitzGerald, R.J., Identification of a novel angiotensin-I converting enzyme inhibitory peptide corresponding to a tryptic fragment of bovine β-lactoglobulin. FEBS Lett. 402 (1997), 99–101.
32. [32] Ktari, N., Jridi, M., Bkhairia, I., Sayari, N., Ben Salah, R., Nasri, M., Functionalities and antioxidant properties of protein hydrolysates from muscle of zebra blenny (Salaria basilisca) obtained with different crude protease extracts. Food Res. Int. 49 (2012), 747–756.
33. [33] Lassoued, I., Mora, L., Nasri, R., Aydi, M., Toldrá, M.F., Aristoy, M.C., et al. Characterization, antioxidative and ACE inhibitory properties of hydrolysates obtained from thornback ray (Raja clavata) muscle. J. Proteome 128 (2015), 458–468.
34. [34] Je, J.Y., Lee, K.H., Lee, M.H., Ahn, C.B., Antioxidant and antihypertensive protein hydrolysates produced from tuna liver by enzymatic hydrolysis. Food Res. Int. 42 (2009), 1266–1272.
35. [35] Jeong, J., Hur, W., Even-numbered peptides from a papain hydrolysate of silk fibroin. J. Chromatogr. B 878 (2010), 836–840.
36. [36] Ngo, D.H., Kang, K.H., Ryu, B.M., Vo, T.S., Jung, W.K., Byun, H.G., et al. Angiotensin-I converting enzyme inhibitory peptides from antihypertensive skate (Okamejei kenojei) skin gelatin hydrolysate in spontaneously hypertensive rats. Food Chem. 174 (2015), 37–43.
37. [37] Birari, R.B., Bhutani, K.K., Pancreatic lipase inhibitions from natural sources: unexplored potential. Drug Discov. Today 12 (2007), 879–889.
38. [38] Kim, T.H., Kim, J.K., Ito, H., Jo, C., Enhancement of pancreatic lipase inhibitory activity of curcumin by radiolytic transformation. Bioorg. Med. Chem. Lett. 21 (2011), 1512–1514.
39. [39] Park, S.Y., Cho, S.A., Lim, S.D., Application of response surface methodology (RSM) for optimization of anti-obesity effect in fermented milk by Lactobacillus plantarum Q180. Korean J. Food Sci. An. 34 (2014), 836–843.
40. [40] Nguyen, C., Mannino, M., Gardiner, K., Cios, K.J., ClusFCM: an algorithm for predicting protein functions using homologies and protein interactions. J. Bioinforma. Comput. Biol. 6 (2008), 203–222.
41. [41] Lafontan, M., Langin, D., Lipolysis and lipid mobilization in human adipose tissue. Prog. Lipid Res. 48 (2009), 275–297.
42. [42] Jandacek, R.J., Woods, S.C., Pharmaceutical approaches to the treatment of obesity. Drug Discov. Today 15 (2004), 874–880.
43. [43] Cudennec, B., Fouchereau-Peron, M., Ferry, F., Duclos, E., Ravallec, R., In vitro and in vivo evidence for a satiating effect of fish protein hydrolysate obtained from blue whiting (Micromesistius poutassou) muscle. J. Funct. Foods 4 (2012), 271–277.
44. [44] Jeon, S.M., Kim, H.K., Kim, H.J., Do, G.M., Jeong, T.S., Park, Y.B., et al. Hypocholesterolemic and antioxidative effects of naringenin and its two metabolites in high-cholesterol fed rats. Transl. Res. 149 (2007), 15–21.
45. [45] Tauseef, M., Sharma, K.K., Fahim, M., Aspirin restores normal baroreflex function in hypercholesterolemic rats by its antioxidative action. Eur. J. Pharmacol. 56 (2007), 136–143.
46. [46] Mustad, V.A., Etherton, T.D., Cooper, A.D., Mastro, A.M., Pearson, T.A., Jonnalagadda, S.S., et al. Reducing saturated fat intake is associated with increased levels of LDL receptors on mononuclear cells in healthy men and women. J. Lipid Res. 38 (1997), 459–468.
47. [47] Westerweel, P.E., Luyten, R.K., Koomans, H.A., Derksen, R.H., Verhaar, M.C., Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus. Arthritis Rheum. 56 (2007), 1384–1396.
48. [48] Young, C.E., Karas, R.H., Kuvin, J.T., High-density lipoprotein cholesterol and coronary heart disease. Cardiol. Rev. 12 (2004), 107–119.
49. [49] Hosomi, R., Fukao, M., Fukunaga, K., Okuno, M., Yagita, R., Kanda, S., et al. Effect of fish protein and peptides on lipid absorption in rats. Trace Nutrients Res. 27 (2010), 21–27.
50. [50] Howard, A., Udenigwe, C.C., Mechanisms and prospects of food protein hydrolysates and peptide-induced hypolipidaemia. Food Funct. 4 (2013), 40–51.
51. [51] Udenigwe, C.C., Rouvinen-Watt, K., The role of food peptides in lipid metabolism during dyslipidemia and associated health conditions. Int. J. Mol. Sci. 16 (2015), 9303–9313.
52. [52] Iritani, N., Hosomi, H., Fukuda, H., Ikeda, H., Polyunsaturated fatty acid regulation of lipogenic enzyme gene expression in liver of genetically obese rat. Biochim. Biophys. Acta 1255 (1995), 1–8.
53. [53] Iritani, N., Hosomi, H., Fukuda, H., Tada, K., Ikeda, H., Soybean protein suppresses hepatic lipogenic enzyme gene expression in Wistar fatty rats. J. Nutr. 126 (1996), 380–388.
54. [54] Ktari, N., Nasri, R., Mnafgui, K., Hamden, K., Belguith, O., Boudaouara, T., et al. Antioxidative and ACE inhibitory activities of protein hydrolysates from zebra blenny (Salaria basilisca) in alloxan-induced diabetic rats. Process Biochem. 49 (2014), 890–897.
55. [55] Olshansky, S.J., Passaro, D.J., Hershow, R.C., Layden, J., Carnes, B.A., Brody, J., et al. A potential decline in life expectancy in the United States in the 21st century. N. Engl. J. Med. 352 (2005), 1135–1137.
56. [56] Halpern, A., Mancini, M.C., Treatment of obesity: an update on anti-obesity medications. Obes. Rev. 4 (2003), 25–42.
57. [57] McDougall, G.J., Kulkarni, N.N., Stewart, D., Berry polyphenols inhibit pancreatic lipase activity in vitro. Food Chem. 115 (2009), 193–199.
58. [58] Hertog, M.G., Feskens, E.J., Hollman, P.C., Katan, M.B., Kromhout, D., Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 342 (1993), 1007–1011.
59. [59] Knekt, P., Jarvinen, R., Reunanen, A., Maatela, J., Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ 312 (1996), 478–481.